Estrogen-dependent activation of NCOA3 couples with p300 and NF-κB to mediate antiapoptotic genes in ER-positive breast cancer cells
暂无分享,去创建一个
[1] A. Kawiak,et al. Regulation of Bcl-2 Family Proteins in Estrogen Receptor-Positive Breast Cancer and Their Implications in Endocrine Therapy , 2022, Cancers.
[2] A. Welm,et al. An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer , 2021, Breast Cancer Research.
[3] A. Letai,et al. ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins , 2021, Cells.
[4] Zhi Chen. The transrepression and transactivation roles of CtBPs in the pathogenesis of different diseases , 2021, Journal of Molecular Medicine.
[5] J. Zeng,et al. A Hypoxia-Induced SCFFBXL1 E3 Ligase Ubiquitinates and Degrades the MEN1 Tumor Suppressor to Promote Colorectal Cancer Tumorigenesis , 2021, Cancer research and treatment.
[6] Zhi Chen,et al. The Monocyte-Derived Exosomal CLMAT3 Activates the CtBP2-p300-NF-κB Transcriptional Complex to Induce Proinflammatory Cytokines in ALI , 2020, Molecular therapy. Nucleic acids.
[7] Matteo Lambrughi,et al. Alterations of the interactome of Bcl-2 proteins in breast cancer at the transcriptional, mutational and structural level , 2019, PLoS Comput. Biol..
[8] H. Salehiniya,et al. Epidemiological characteristics of and risk factors for breast cancer in the world , 2019, Breast cancer.
[9] Suxia Han,et al. Nuclear Receptor Coactivator 2 Promotes Human Breast Cancer Cell Growth by Positively Regulating the MAPK/ERK Pathway , 2019, Front. Oncol..
[10] N. Bowden,et al. BCL-2 family isoforms in apoptosis and cancer , 2019, Cell Death & Disease.
[11] S. Tait,et al. Targeting BCL-2 regulated apoptosis in cancer , 2018, Open Biology.
[12] C. Duvall,et al. Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers , 2018, Cell Death & Disease.
[13] G. Kalna,et al. MCL-1 is a prognostic indicator and drug target in breast cancer , 2018, Cell Death & Disease.
[14] Carmela Fimognari,et al. Broad targeting of resistance to apoptosis in cancer , 2015, Seminars in cancer biology.
[15] R. Cook,et al. Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance? , 2015, Oncotarget.
[16] O. Yersal,et al. Biological subtypes of breast cancer: Prognostic and therapeutic implications. , 2014, World journal of clinical oncology.
[17] E. Henson,et al. Estrogen Regulation of Anti-Apoptotic Bcl-2 Family Member Mcl-1 Expression in Breast Cancer Cells , 2014, PloS one.
[18] Xinmin Zhou,et al. Regulation of Mcl-1 by constitutive activation of NF-kappaB contributes to cell viability in human esophageal squamous cell carcinoma cells , 2014, BMC Cancer.
[19] Ö. Türeci,et al. NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells , 2013, BMC Cancer.
[20] Zhongyu Yuan,et al. Efficacy and tolerability of toremifene and tamoxifen therapy in premenopausal patients with operable breast cancer: a retrospective analysis. , 2013, Current oncology.
[21] S. Tait,et al. Multiple functions of BCL-2 family proteins. , 2013, Cold Spring Harbor perspectives in biology.
[22] V. Tam,et al. A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERα protein. , 2012, Carcinogenesis.
[23] B. O’Malley,et al. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1. , 2011, Molecular endocrinology.
[24] F M Blows,et al. BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received , 2010, British Journal of Cancer.
[25] A. Onitilo,et al. Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival , 2009, Clinical Medicine & Research.
[26] F. Bray,et al. The changing global patterns of female breast cancer incidence and mortality , 2004, Breast Cancer Research.
[27] A. Wellstein,et al. Effect of estradiol on estrogen receptor-α gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway , 2003, Oncogene.
[28] S. Catz,et al. Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer , 2001, Oncogene.
[29] W. Zong,et al. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis , 1999 .
[30] J. G. McGuire. What in the world? , 1996, The Journal of school health.
[31] C Gélinas,et al. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. , 1999, Genes & development.
[32] L. Leung,et al. © 1999 Cancer Research Campaign Article no. bjoc.1999.0706 Paradoxical regulation of Bcl-2 family proteins by , 2022 .